...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Question for the board!

,,hummm,,what is the basic purpose for keeping Zenith Capital Corp. off an exchange? I am sort of lost as to why such a company wnats to remain protected from open market dynamics. I assume Management has a good reason but I am lost as to why.

Share
New Message
Please login to post a reply